AI assistant
SOLARA ACTIVE PHARMA SCIENCES LIMITED — Board/Management Information 2023
Nov 14, 2023
61842_rns_2023-11-14_f5dd7f3f-91c5-4f60-b4a6-2874f1e612ea.pdf
Board/Management Information
Open in viewerOpens in your device viewer
Communication Address: Solara Active Pharma Sciences Limited 2nd Floor, Admin Block 27, Vandaloor Kelambakkam Road, Keelakottaiyur Village, Melakottaiyur (Post) Chennai – 600 127, India Tel: +91 44 43446700 Fax: +91 44 47406190 E-mail: [email protected] www.solara.co.in
November 14, 2023
The BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Bandra-Kurla Complex Dalal Street, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 541540 Scrip Code: SOLARA
Dear Sirs,
- Sub: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) – Appointment of Directors
Pursuant to Regulation 30 of the SEBI Listing Regulations, we hereby inform you based on the recommendations of the Nomination and Remuneration Committee, the Board of Directors of the Company at its meeting held today, (November 14, 2023), appointed Mr. Rajendra Kumar Srivastava (DIN: 07500741) as Additional Non-Executive Independent Director and Mr. Rajiv Vijay Nabar (DIN: 10383397) as Additional Non-Executive Non-Independent Director of the Company, subject to approval of the shareholders. The required details pursuant to SEBI Listing Regulations are annexed herewith as Annexure – I.
We hereby confirm that Mr. Rajendra Kumar Srivastava satisfies the criteria of independence prescribed under the Companies Act, 2013 and SEBI Listing Regulations.
We also confirm that they are not debarred from holding the office of Director by virtue of any order passed by SEBI or any other such authority.
We request you to take the same on record.
Thanking you,
Yours faithfully, For Solara Active Pharma Sciences Limited
SUDDAPALLI Digitally signed by SUDDAPALLI MURALIKRISHNA MURALIKRISHNA Date: 2023.11.14 15:45:06 +05'30'
S. Murali Krishna Company Secretary
Encl.: As above
Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636 REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942
Communication Address: Solara Active Pharma Sciences Limited 2nd Floor, Admin Block 27, Vandaloor Kelambakkam Road, Keelakottaiyur Village, Melakottaiyur (Post) Chennai – 600 127, India Tel: +91 44 43446700 Fax: +91 44 47406190 E-mail: [email protected] www.solara.co.in
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
ANNEXURE 1
| Name of Director | Rajendra Kumar Srivastava (DIN: 07500741) | |
|---|---|---|
| Reason for change viz. appointment, re-appointment, resignation, removal, death or otherwise |
Mr. Rajendra Kumar Srivastava is appointed as an Additional Non-Executive Independent Director with effect from November 14, 2023 subject to approval of the shareholders of the Company |
|
| Date of Appointment / ~~R~~~~e-~~ ~~appointment/Cessation~~ |
November 14, 2023 | |
| ~~appoe~~ | ||
| Term of appointment | 5 years i.e., November 14, 2023, to November 13, 2028 | |
| Brief profile | Mr. Rajendra Srivastava is the Novartis Professor of Marketing Strategy and Innovation at the Indian School of Business (ISB) (Hyderabad & Mohali). He has served Dean at ISB and is Executive Director for ISB’s Centre for Business Innovation and Executive Fellows Program in Management. He has also served as Provost and Deputy President at Singapore Management University and as Senior Associate Dean at both Emory University and The University of Texas at Austin. He is an independent director on the board of Happiest Minds Technologies, a listed company. A pracademic (practical academic) at heart, he is a strong proponent for inter-disciplinary research and collaboration between industry, government, and academia. His academic leadership and contributions to the field of Marketing focusing on brand equity, marketing-finance interface and market-based intangible assets have been recognized by American Marketing Association which appointed him as a 2020 AMA Fellow. He is a member of the EQUIS Committee of the European Foundation for Management Development (EFMD). He is also a Senior Research Fellow at the Mack Institute for Innovation (Wharton), and the Institute for Studies in Business Markets (ISBM) at Penn State. |
|
| Disclosure of relationship between directors |
Mr. Rajendra Kumar Srivastava is not related to any Director of the Company. |
|
| Other Directorships / Memberships (in listed entities in case of resignation of Independent director) |
Not Applicable |
Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636 REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942
Communication Address: Solara Active Pharma Sciences Limited 2nd Floor, Admin Block
27, Vandaloor Kelambakkam Road, Chennai – 600 127, India Tel: +91 44 43446700 Fax: +91 44 47406190 E-mail: [email protected] www.solara.co.in
Keelakottaiyur Village, Melakottaiyur (Post)
| Name of Director | Mr. Rajiv Vijay Nabar (DIN: 10383397) | |
|---|---|---|
| Reason for change viz. appointment, re-appointment, resignation, removal, death or otherwise |
Mr. Rajiv Vijay Nabar is appointed as an Additional Non- Executive Non-Independent Director with effect from November 14, 2023 subject to approval of the shareholders of the Company |
|
| Date of Appointment / ~~R~~~~e-~~ ~~appointment/Cessation~~ |
November 14, 2023 | |
| ~~appoe~~ | ||
| Term of appointment | Not Applicable | |
| Brief profile | Mr. Rajiv Vijay Nabar has served as the Principal Chief Commissioner of Income Tax and has been a distinguished member of the Indian Revenue Service since 1986. With over 35 years of experience, he possesses expertise in Direct Taxes, International Taxation, Investigations, and Exemptions. He also served as the Member Secretary of the CBDT Committee for Speculative Transactions. During his tenure at SEBI from 1992 to 1997, where he served as a Division Chief in its formative years, he achieved significant accomplishments. These include developing the Stock Watch System, playing a pivotal role in the creation of the Depositories Act, and setting up procedures in the Investigation arm. He presided as the Chairman of the SEBI Committee for Cash Flow Statement standards and Listing Agreement. He also served on the Boards of several stock exchanges. Rajiv holds a Gold Medal in B.Sc. (Hons) from the University of Delhi. He earned an M.A in Social Work from DSSW and holds a Diploma in Industrial Relations and Personnel Management from Bhartiya Vidya Bhavan, Delhi. |
|
| Disclosure of relationship between directors |
Mr. Rajiv Vijay Nabar is not related to any Director of the Company. |
|
| Other Directorships / Memberships (in listed entities in case of resignation of Independent director) |
Not Applicable |
Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636 REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942